Amygdalin (Vitamin B17) as a Natural Bioactive Compound Attenuates Polycystic Ovary Syndrome through Modulation of PPAR-γ/SREBP-1c Gene Expression: A Comparative Preclinical Study with Metformin
Polycystic Ovary Syndrome (PCOS) affects 8-13% of reproductive- age women worldwide and is characterized by metabolic, hormonal, and oxidative stress disturbances. Current therapies such as metformin provide symptomatic relief but do not address the multifactorial pathophysiology. This study aimed to evaluate the t...